Nigeria: Congo to Start Using Johnson & Johnson Ebola Vaccine in November

14 October 2019

Health authorities in the Democratic Republic of Congo will introduce a Johnson & Johnson Ebola vaccine in November in the country's eastern provinces, to counter the current outbreak, they said.

The J&J vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people. It requires two injections eight weeks apart, unlike the Merck vaccine, which requires a single shot.

The first batch of 500,000 doses of the J&J vaccine should arrive in Congo next week, the authorities said in a statement. The inoculation process will start in Goma in early November and then be extended to other provinces, Reuters reported.

Congolese health authorities had announced the deployment of the vaccine last month but had not specified when the campaign will take place.

Since it first started in August 2018, the Ebola outbreak has killed more than 2,100 people, second only to the 2013-16 outbreak in West Africa that killed more than 11,300.

See What Everyone is Watching

More From: Vanguard

Don't Miss

AllAfrica publishes around 700 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.